
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Med.
Sec. Obstetrics and Gynecology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1529894
This article is part of the Research TopicAdvancements in Diagnostic and Management Strategies for Gynecological PathologiesView all 15 articles
The final, formatted version of the article will be published soon.
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Translation of fertility risk by whole-exome sequencing of family lines to find variants that explain the clinical phenotype of patients.1. Using techniques such as amniotic fluid, chorionic villus, or umbilical cord blood sampling, intact fetal cells were extracted for cell culture and subsequently analyzed using chromosomal karyotyping and chromosomal microarray techniques.2. With fully informed consent, fetuses and their parents whose genetic etiology could not be detected by karyotyping combined with chromosomal microarray technology had their cellular DNA subjected to whole exome sequencing of the pedigree.3. Pathogenic variants were screened, combined with fetal ultrasound phenotyping and ACMG variant rating guidelines for variant interpretation, followed by inviting multidisciplinary experts to conduct in-depth analysis and indicating fetal-related ultrasound abnormalities.4.Genetic counseling is assisted based on the results.1. Of the 357 fetuses included in the study, 33 (33/357, 9.24%) had a successful genetic etiology identified by family-wide exome sequencing combined with ultrasound phenotyping.2. The results showed that skeletal anomalies were the most frequent, II accounting for 15 cases (15/33, 45.45%), followed by multiple malformations in 7 cases (7/33, 21.21%), renal anomalies in 3 cases (3/33, 9.09%), soft index anomalies in 2 cases (2/33, 6.06%), neurological anomalies in 2 cases (2/33, 6.06%), cleft lip and palate in 1 case (1/33, 3.03%), cardiac abnormality in 1 case (1/33, 3.03%), hydatidiform mole in 1 case (1/33, 3.03%), and cataract in 1 case (1/33, 3.03%). 3. During whole exome sequencing, three previously unreported variant sites were identified: MSX2 (NM_002449.4: c.423_427dupCAATC, p.Arg143Profs*39), EVC (NM_153717.2: c.130delC, p.Leu44Phefs*72), and RYR1 (NM_000540.2: c.14129+1 G>A).1. This study provides robust data supporting the application of whole exome sequencing of family lines in clinical practice, offering valuable reference information for clinicians.2. The newly discovered variants hold significant value for enhancing the relevant genetic databases.with the pregnancy and future reproductive choices..
Keywords: whole exome sequencing, Prenatal Diagnosis, Structural abnormalities, Genetics, Ultrasound technology
Received: 18 Nov 2024; Accepted: 15 Apr 2025.
Copyright: © 2025 Ge, Yuan, Zeng, Xiao, Liu, Peng, Huang, Yang, Zou and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yijun Ge, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Supplementary Material
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.